{"id":6728,"date":"2020-12-15T12:39:45","date_gmt":"2020-12-15T01:39:45","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?page_id=6728"},"modified":"2024-09-05T12:50:39","modified_gmt":"2024-09-05T02:50:39","slug":"hypotonic-hyporesponsive-episode-hhe","status":"publish","type":"references","link":"https:\/\/mvec.mcri.edu.au\/hi\/references\/hypotonic-hyporesponsive-episode-hhe\/","title":{"rendered":"\u0939\u093e\u0907\u092a\u094b\u091f\u094b\u0928\u093f\u0915-\u0939\u093e\u0907\u092a\u094b\u0930\u0947\u0938\u094d\u092a\u0949\u0928\u094d\u0938\u093f\u0935 \u090f\u092a\u093f\u0938\u094b\u0921 (\u090f\u091a\u090f\u091a\u0908)"},"content":{"rendered":"
<\/p>\n

\u092a\u0943\u0937\u094d\u0920\u092d\u0942\u092e\u093f<\/h2>\n

A hypotonic-hyporesponsive episode (HHE) is defined as the sudden onset of hypotonia (muscle limpness), reduced responsiveness or unresponsiveness, and skin colour changes (pallor or cyanosis) occurring after vaccination in early childhood (< 2 years of age).<\/span>\u00a0<\/span><\/p>\n

HHEs can occur in the period immediately following vaccination, or up to 48 hours after vaccine administration (delayed HHE). The average episode lasts 6 to 30 minutes.<\/span>\u00a0<\/span><\/p>\n

HHEs resolve spontaneously, with most children returning to their pre-vaccination state within 6 hours. <\/span>There are no long-term sequelae (conditions caused by a previous disease or injury) from having an HHE.<\/span><\/p>\n

Diagnosis<\/h2>\n

HHEs are diagnosed based on clinical presentation (e.g. symptoms, timing, resolution of symptoms). Investigations are not helpful for confirming a diagnosis of HHE; this is because HHEs present with transient, self-limiting (resolve on their own) symptoms, and have no long-term sequelae.<\/span>\u00a0<\/span><\/p>\n

Investigations may, however, be useful to exclude other diagnoses such as seizure activity or an allergic reaction<\/a> (e.g. wheezing, rash or hives).<\/span>\u00a0<\/span><\/p>\n

Immediate HHEs can appear\u00a0like an immediate vasovagal phenomenon (a fainting episode) but there are some key differences. Fainting episodes present with similar signs and symptoms (e.g. muscle limpness, unresponsiveness, pallor) but with drops in blood pressure and heart rate, usually presenting in an older age group (\u2265 2 years of age). HHEs are often preceded by crying and breath holding, with vital signs remaining stable.<\/span>\u00a0<\/span><\/p>\n

\u0938\u0902\u0918 \u0914\u0930 \u0918\u091f\u0928\u093e\u090f\u0901<\/h2>\n

HHEs can occur after any immunisation regardless of the type of vaccine; historically, HHEs were most associated with whole-cell \u092a\u0930\u094d\u091f\u0941\u0938\u093f\u0938,<\/a> vaccines in early infancy. There has been a decrease in HHE incidence since the change from using whole-cell to acellular pertussis vaccines.<\/span>\u00a0<\/span><\/p>\n

HHE has been observed most often after the first doses of vaccines at 6 to 8 weeks of age. In 2012, 2.2 cases of HHE were reported per 100,000 doses of pertussis-containing vaccine given to children under 1 year of age.<\/span>\u00a0<\/span><\/p>\n

The cause of HHEs is yet to be determined.<\/span><\/p>\n

\u0907\u0932\u093e\u091c<\/h2>\n

HHEs self-resolve and do not need any active treatment.<\/span>\u00a0<\/span><\/p>\n

Assessment of airway, breathing and circulation is advised as a basic precaution. This can exclude other diagnoses. Careful clinical observation and documentation of the event are vital for a differential diagnosis.\u00a0<\/span>\u00a0<\/span><\/p>\n

Suspected HHE should be assessed by a medical professional.<\/span>\u00a0<\/span><\/p>\n

\u092d\u0935\u093f\u0937\u094d\u092f \u0915\u0940 \u0916\u0941\u0930\u093e\u0915 \u0915\u0947 \u0932\u093f\u090f \u0928\u093f\u0939\u093f\u0924\u093e\u0930\u094d\u0925<\/h2>\n

HHE is not a contraindication to further doses of vaccines, including pertussis-containing vaccines. Recurrence rates of a further HHE following subsequent immunisations are\u00a0low (3.5%).<\/span>\u00a0<\/span><\/p>\n

Your local <\/span>\u091f\u0940\u0915\u093e \u0938\u0941\u0930\u0915\u094d\u0937\u093e \u0938\u0947\u0935\u093e<\/span><\/a> can provide advice on whether subsequent vaccines needs to be administered under a period of observation.<\/span>\u00a0<\/span><\/p>\n

Any adverse event following immunisation (AEFI), including HHEs, in Victoria should be reported to <\/span>\u0938\u0948\u092b\u0935\u093f\u0915<\/span><\/a>.<\/span>\u00a0<\/span><\/p>\n<\/div>

<\/p>\n

\u0938\u0902\u0938\u093e\u0927\u0928<\/h2>\n